Prevalence and relationship with health of off-label and contraindicated drug use in the United States: a cross-sectional study
Off-label and contraindicated drug use is prevalent in outpatient prescriptions and is associated with worse health outcomes and increased healthcare utilisation. These findings suggest a need for enhanced monitoring and regulatory measures to minimise risks associated with inappropriate prescription practices.
Authors
- Frank R. Lichtenberg (ORCID: https://orcid.org/0000-0002-5113-9681)
- Katharina Elisabeth Blankart (ORCID: https://orcid.org/0000-0001-9831-1787)
Institutions
- National Bureau of Economic Research (US)
- University of Duisburg-Essen (DE)
- Columbia University (US)
Publication Details
- Journal
- Journal of Pharmaceutical Policy and Practice
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1080/20523211.2025.2472221
- Citations
- 5
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 17.47